Lemborexant Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Also known as: Dayvigo

Pipeline

Phase 2: 1

Top Sponsors

Unity Health Toronto1

Indications

Insomnia Comorbid to Psychiatric Disorder1
Major Depressive Disorder (MDD)1
Depression1

Other1 trial

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.